BUTLER NATIONAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BUTLER NATIONAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 30, 2018 | $48.26M | Jul 20, 2018 |
| FY2018 | Apr 30, 2017 | $50.62M | Jul 20, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Apr 30, 2017 | $50.62M | Jul 21, 2017 |
| FY2016 | Apr 30, 2016 | $11.93M | Jul 27, 2016 |
| FY2016 | Jan 31, 2016 | $11.07M | Jul 27, 2016 |
| FY2016 | Oct 31, 2015 | $10.11M | Jul 27, 2016 |
| FY2016 | Jul 31, 2015 | $11.70M | Jul 27, 2016 |
| FY2015 | Apr 30, 2015 | $11.84M | Jul 29, 2015 |
| FY2015 | Jan 31, 2015 | $11.08M | Jul 29, 2015 |
| FY2015 | Oct 31, 2014 | $11.75M | Jul 29, 2015 |
| FY2015 | Jul 31, 2014 | $12.39M | Jul 29, 2015 |
| FY2014 | Apr 30, 2014 | $14.63M | Jul 29, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $12.55M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $12.51M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $4.52M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $10.37M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $1.43M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $4.23M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $3.85M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $341.0K | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $1.53M | Jul 20, 2018 |
| FY2016 | Apr 30, 2016 | $381.0K | Jul 27, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $16.83M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $13.24M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $8.65M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $16.13M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $5.90M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $8.31M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $5.28M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $2.12M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $3.50M | Jul 20, 2018 |
| FY2016 | Apr 30, 2016 | $418.0K | Jul 27, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $952.0K | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $823.0K | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $1.07M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $2.35M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $3.49M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $2.40M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $1.89M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $1.76M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $1.48M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $1.84M | Jul 21, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $18.40M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $7.54M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $20.94M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $11.18M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $13.46M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $10.04M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $9.56M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $6.31M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $6.00M | Jul 20, 2018 |
| FY2016 | Apr 30, 2016 | $2.42M | Jul 27, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $8.26M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $8.74M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $6.51M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $9.58M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $6.99M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $3.17M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $4.99M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $2.29M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $3.18M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $2.76M | Jul 21, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $123.30M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $113.98M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $113.91M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $100.81M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $101.92M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $94.78M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $48.90M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $41.43M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $42.78M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $42.70M | Jul 21, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $58.18M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $59.53M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $67.13M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $59.98M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $60.54M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $56.98M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $14.56M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $12.17M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $14.48M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $16.60M | Jul 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $65.11M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $54.44M | Jul 3, 2025 |
| FY2025 | Apr 30, 2023 | $46.78M | Jul 3, 2025 |
| FY2022 | Apr 30, 2022 | $40.83M | Jul 15, 2022 |
| FY2022 | Apr 30, 2021 | $35.36M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $32.81M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $28.00M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $24.00M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $23.59M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $21.81M | Jul 21, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $59.53M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $46.98M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $34.46M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $29.95M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $19.58M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $18.15M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $13.91M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $10.06M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $9.72M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $8.19M | Jul 21, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $35.16M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | $38.11M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | $43.41M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | $48.58M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | $45.79M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | $5.44M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | $3.98M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | $3.35M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | $5.64M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | $7.68M | Jul 21, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | 0 | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | 0 | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | 0 | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | 0 | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | 0 | Jul 20, 2018 |
| FY2016 | Apr 30, 2016 | 0 | Jul 27, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | 0 | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | 0 | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | 0 | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | 0 | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | 0 | Jul 20, 2018 |
| FY2016 | Apr 30, 2016 | 0 | Jul 27, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 67.18M | Jul 3, 2025 |
| FY2025 | Apr 30, 2024 | 68.77M | Jul 3, 2025 |
| FY2024 | Apr 30, 2023 | 76.89M | Jul 23, 2024 |
| FY2023 | Apr 30, 2022 | 76.46M | Jul 31, 2023 |
| FY2022 | Apr 30, 2021 | 75.37M | Jul 15, 2022 |
| FY2021 | Apr 30, 2020 | 74.40M | Jul 16, 2021 |
| FY2020 | Apr 30, 2019 | 68.28M | Jul 17, 2020 |
| FY2019 | Apr 30, 2018 | 64.74M | Jul 19, 2019 |
| FY2018 | Apr 30, 2017 | 64.54M | Jul 20, 2018 |
| FY2017 | Apr 30, 2016 | 63.47M | Jul 21, 2017 |